Vabomere
Payments companies reported to CMS as associated with Vabomere. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vabomere, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vabomere
These are the largest totals companies reported as associated with Vabomere. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Wikler | San Diego, CA | Infectious Disease | $98,361.50 |
| Paula Bokesch | Lexington, MA | Anesthesiology | $54,900.00 |
| Marya Zilberberg | Leeds, MA | Pulmonary Disease | $41,500.00 |
| Brandon Smith | Pittsburgh, PA | Infectious Disease | $12,694.10 |
| Shaker Itani | Las Vegas, NV | Infectious Disease | $11,579.41 |
| Christian Sandrock | Sacramento, CA | Internal Medicine | $11,479.08 |
| John Bradley | San Diego, CA | Pediatric Infectious Diseases | $8,735.04 |
| Arthur Jeng | Sylmar, CA | Infectious Disease | $7,158.95 |
| Toral Patel | Chicago, IL | Internal Medicine | $7,070.40 |
| Bruce Friedman | Augusta, GA | Critical Care Medicine (Internal Medicine) | $5,905.92 |
Prescribed Vabomere?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.